Silencing TNF-α in macrophages and dendritic cells for arthritis treatment
Autor: | Chunting Ye, P Shankar, V Deshpande, N Manjunath, Atul K. Bhan |
---|---|
Rok vydání: | 2013 |
Předmět: |
Lipopolysaccharides
Small interfering RNA Necrosis Lipopolysaccharide Immunology Arthritis Mice Random Allocation Viral Proteins chemistry.chemical_compound Rheumatology Reference Values medicine Animals Immunology and Allergy Gene silencing Gene Silencing Glycoproteins Mice Inbred BALB C Gene knockdown biology Tumor Necrosis Factor-alpha business.industry Macrophages Biopsy Needle Dendritic Cells General Medicine medicine.disease Arthritis Experimental Immunohistochemistry Molecular biology Peptide Fragments Disease Models Animal Treatment Outcome chemistry Mice Inbred DBA biology.protein Tumor necrosis factor alpha Antibody medicine.symptom business |
Zdroj: | Scandinavian Journal of Rheumatology. 42:266-269 |
ISSN: | 1502-7732 0300-9742 |
Popis: | Tumour necrosis factor (TNF)-α secreted by macrophages and dendritic cells (DCs) plays a predominant role in arthritis. Our previous studies suggest that a small peptide, RVG-9R (29-aa peptide derived from the rabies virus glycoprotein, fused to 9R residues), can deliver small interfering RNA (siRNA) to macrophages and DCs. We therefore tested whether knockdown of TNF-α expression in macrophages and DCs by RVG-9R/bound siRNA targeting TNF-α reduces the severity of collagen antibody-induced arthritis (CAIA) in mice.Arthritis was induced in mice by injecting a combination of antibodies to collagen followed by lipopolysaccharide (LPS) treatment. Mice were also injected with TNF-α siRNA complexed with RVG-9R peptide or an irrelevant peptide RVMAT-9R on days 1, 3, 5, and 7. As a positive control, dexamethasone was injected intravenously. Paw thickness was measured every 2 days and the mice were killed on day 10 for testing synovial TNF-α levels and histological analysis of joints.In control mice, arthritis developed on day 4 and reached its peak between day 7 and day 9. Treatment with siTNF-α bound to RVG-9R, but not to RVMAT-9R, resulted in reducing paw thickness scores to the same level as dexamethasone treatment, associated with reduced TNF-α level in synovial fluid. Histological analysis of joints in the control RVMAT-9R/TNF-α siRNA-treated mice showed marked pannus formation and destruction of cartilage and subchondrial bone, as well as severe infiltration of inflammatory cells into the synovium. By contrast, the joint pathology was markedly reduced in RVG-9R/TNF-α siRNA-treated mice resembling the dexamethasone-treated mice.Suppression of TNF-α expression in macrophages and DCs by RVG-9R-mediated siRNA delivery could potentially be a clinically viable strategy for treatment of arthritis. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |